POST-DOCTORAL POSITION IN VIROLOGY
The team EVIR – Enveloped viruses, Vectors and Immunotherapy – at CIRI is welcoming applications from enthusiastic and independent post-doctoral candidates to participate to join research projects on cellular and molecular aspects of assembly and cell entry of HBV particles, interconnection with cellular pathways and mechanisms of HDV/HBV co-infection. The position is available for three years
Contact: François-Loïc Cosset
POST-DOCTORAL POSITION IN IMMUNO-VIROLOGY.
The team Molecular Basis of Viral Pathogenicity is currently looking for a post doc for a 1-year contract that is immediately available. The team is involved in deciphering the high pathogenesis of viral hemorrhagic fever viruses and notably Ebola, Marburg, Nipah and CCHFV. We are seeking motivated scientists to reinforce the team and accelerate the current ongoing projects.
Contact: Viktor Volchkov or Olivier Reynard
INGENIEUR-E EN BIO-INFORMATIQUE
L’ingénieur-e exercera ses activités au sein du Centre International de Recherche en
Infectiologie (CIRI) sur le site de l’ENS de Lyon (Gerland). Il/Elle prendra en charge des développements informatiques dans le domaine d’analyses de données issues de
séquençage/technologie haut-débit, et le déploiement de la bio-informatique dans le Centre. CDD INSERM 1 an, renouvelable
Contact : Lucie Etienne
POST-DOCTORAL POSITION IN IMMUNO-VIROLOGY
A three-year postdoctoral position is available in our laboratory starting from January 2020, to study immunobiology of Nipah virus infection in its natural host and develop novel therapeutic anti-viral approaches.
Contact : Branka Horvat
POST-DOC POSITION IN IMMUNO-VIROLOGY
We are currently inviting applications from enthusiastic post-doctoral candidates (2-year position) or PhD student (3-year position) to participate in our project supported by the French National Agency (ANR JCJC)
Contact: Marlène Dreux
(05 Aout 2019)
ENGINEER POSITION IN VIROLOGY
L’ingénieur(e) sera impliqué(e) sur un projet de thérapie génique au sein de l’équipe « Enveloped Viruses, Vectors & Immunotherapy » (EVIR)
La durée du contrat est de 1 an renouvelable
Contact: Els Verhoeyen
(18 juillet, 2019)
ENGINEER POSITION IN IMMUNO-VIROLOGY
We are currently inviting applications from enthusiastic engineer to participate in our project supported by the French National Agency.
The research program centers on viruses and innate immunity, espacially the interferon response. This position is opened with a 6 month contract renewable.
Contact: Marlene Dreux
(May 11th, 2019)
Post-doc position in Immuno-Bacteriology.
Thomas Henry’s team is looking for a highly motivated applicant with a PhD in immunology and/or expertise in the field of primary human cells, inflammasome and/or innate immunity. Expertise in imaging would be also considered. The research project will focus on characterizing inflammasomes dysregulation in various autoinflammatory syndromes. This position is opened starting in April 2019 with a one year contract renewable for up to 4 years.
Contact: Thomas Henry
Post-doc position in virology
Host Pathogen Interaction in Lentiviral Infection Laboratory is actively seeking for one highly motivated post doctoral candidate to work on the relationship between human immunodeficiency viruses (HIVs) and the family of Interferon-Induced Transmembrane Proteins (IFITMs), exciting antiviral effectors capable of targeting HIV as well as a broad range of very distinct viruses. IFITMs block the fusion between viral and cellular membranes and the goal of the project is to determine the exact mechanism through which this is orchestrated.
Contact: Dr. Andrea Cimarelli
(January 10th, 2019)
Post-doc position in viro-immunology
We are currently inviting applications from enthusiastic post-doctoral candidates (2-year position) or PhD student (3-year position) to participate in our project supported by the French National Agency.
The research program centers on viruses and innate response: single cell monitoring of antiviral response and translation arrest in the course of infections
Contact: Dr. Marlène DREUX
(January 10th, 2019)